Concepedia

Aravind Kancharla

AK

Statistics

Publications

4

Citations

108

H-Index

4

Active since

2021

Affiliations

The University of Texas at San Antonio(Current)

The University of Texas at San Antonio Health Science Center

Mays Cancer Center at UT Health San Antonio

Aravind Kancharla is an author at The University of Texas at San Antonio specializing in oncology, immunotherapy, and cancer immunology.

Publications per year

2021–2023

4

Publications

4

Bladder cancer cell‐intrinsic PD‐L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy

Deyi Zhang, Ryan M. Reyes, Erica Osta et al. · Cancer Medicine · 2021 · 46 citations · Full text

Medicine, Oncology, Pharmacology +17

Immune checkpoint expression and relationships to anti‐PD‐L1 immune checkpoint blockade cancer immunotherapy efficacy in aged versus young mice

Myrna Garcia, Yilun Deng, Clare Murray et al. · Aging and Cancer · 2022 · 29 citations · Full text

Life Sciences, Immunology, Oncology +17

CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation

Ryan M. Reyes, Yilun Deng, Deyi Zhang et al. · Journal for ImmunoTherapy of Cancer · 2021 · 22 citations · Full text

Medicine, Oncology, Pharmacology +15

Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects

Haiyan Bai, Álvaro Padrón, Yilun Deng et al. · Journal for ImmunoTherapy of Cancer · 2023 · 11 citations · Full text

Medicine, Oncology, Pharmacology +17

1–4 of 4